Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Radiation Oncology (London, England)|December 23, 2025
Neoadjuvant chemo-reirradiation followed by resection and intraoperative electron beam radiotherapy: outcomes of multimodality treatment for locally recurrent rectal cancerF E C Vande Kerckhove, F Piqeur, E Banken, et al.Annals of Surgical Oncology|January 24, 2026
Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II TrialTeun B M van den Heuvel, Paulien Rauwerdink, Emma Hulshof, et al.Annals of Surgical Oncology|January 22, 2026
Locally Recurrent Rectal Cancer in the Lateral Compartment: Imaging Features and Association with Primary Tumour CharacteristicsF E C Vande Kerckhove, D M J Creemers, E Banken, et al.Annals of Surgical Oncology|February 8, 2023
Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II TrialC Bakkers, K P Rovers, A Rijken, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2025
Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohortD M J Creemers, D M Mens, S Nordkamp, et al.Clinical and Translational Radiation Oncology|April 24, 2025
Multidisciplinary approach to target volume delineation in locally recurrent rectal cancer: An explorative studyF Piqeur, D S C van Gruijthuijsen, J Nederend, et al.European Journal of Cancer (Oxford, England : 1990)|March 23, 2024
Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohortsE G M van Geffen, J M A Langhout, S J A Hazen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2023
Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter TrialEmma Sophia Zwanenburg, Charlotte El Klaver, Daniel D Wisselink, et al.BMC Cancer|September 6, 2022
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)K van den Berg, D P Schaap, E L K Voogt, et al.BMC Cancer|May 19, 2026
A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trialE Banken, M Borg, I E G van Hellemond, et al.Pageof 6